On October 1st this year, Invicta, an infertility treatment clinic, implemented a new AI tool — the AIOO application, which was co-created by MIM Solutions. AlOO predicts the likely number of mature ova obtainable during the in-vitro process. The solution, which is powered by artificial intelligence, bases its prognosis on the patient’s individual laboratory test results and her treatment history.
Together with the application, INVICTA has created a test that allows the assessment of patient’s genetic predispositions. The test makes AIOO prognosis about the number of mature oocytes even more accurate.